Viewing Study NCT01292603


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-29 @ 2:22 PM
Study NCT ID: NCT01292603
Status: COMPLETED
Last Update Posted: 2018-12-19
First Post: 2011-02-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Sponsor: Hoffmann-La Roche
Organization: